Infection Viral Clinical Trial
Official title:
Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy
The Novel Coronavirus (2019-nCoV), also known as Wuhan coronavirus, causes the 2019-nCoV acute respiratory disease.
Coronaviruses (CoVs) are the largest group of viruses belonging to the Nidovirales order.
They are enveloped, non-segmented positive-sense RNA viruses.
Coronavirus are believed to cause a significant proportion of all common colds in adults and
children. The Novel Coronavirus (2019-nCoV), also known as Wuhan coronavirus, causes the
2019-nCoV acute respiratory disease. The initial cases of 2019-nCoV occurred in Wuahn, China
in December 2019.
A recent review evaluated the potential impact of 2019-nCoV in pregnancy. The authors
reported published data on CoVs in pregnant women, including 2019-nCoV, severe acute
respiratory syndrome (SARS-COV) and Middle East respiratory syndrome (MERS-COV). The review
included 12 women with SARS-COV,4 11 women MERS-COV,5 and 9 women with 2019-n-CoV6 in
pregnancy. No cases of vertical trasmission were reported, but the authors showed an high
rate of preterm birth (45.8%), cesarean delivery (70.8%), maternal admission to intensive
care unit (ICU) (63.3%), and maternal death (18.8%).
The aim of this study was to evaluate the pregnancy and perinatal outcomes of pregnant women
with 2019-n-CoV.
This was a multicenter, retrospective, cohort study. Clinical records and compiled data of
all consecutive hospitalized and outpatient pregnant women with laboratory-confirmed
2019-n-CoV Data on recent exposure history, clinical symptoms or signs, laboratory findings,
and maternal and perinatal outcomes were collected. All medical recors were sent to the
coordinator center. Data were entered into a computerized database and cross-checked. If the
core data were missing, requests for clarification were sent to the coordinators.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06178822 -
Towards Novel BIOmarkers to Diagnose SEPsis on the Emergency Room
|
||
| Completed |
NCT05041764 -
RNA Sequencing of Individual Versus Wastewater - SARS-CoV2
|
||
| Completed |
NCT04239521 -
The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata
|
||
| Recruiting |
NCT03818334 -
Post Transplant Cyclophosphamide in Matched Unrelated Donor Stem Cell Transplantation for Hematological Malignancies
|
Phase 2/Phase 3 | |
| Completed |
NCT04637867 -
COVID-19 - Multicentre Study on Nosocomial Transmission of SARS-CoV-2 Virus: an Ancillary Study (NOSO-COR IMMUNO)
|
N/A | |
| Recruiting |
NCT06149494 -
RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection
|
Phase 2 | |
| Completed |
NCT05069623 -
A Phase 1/2 Study to Determine Safety and Immunogenicity of Two COVID 19 Vaccines VB10.2129 (RBD Candidate) and VB10.2210 (T Cell Candidate) Previously Vaccinated in Healthy Adult Volunteers
|
Phase 1/Phase 2 | |
| Recruiting |
NCT04386460 -
Covid-19 and Prevention of Malnutrition After Confinement by Dentists
|
||
| Completed |
NCT04290780 -
COVID-19 - Multicenter Study on Nosocomial Transmission of SARS-CoV-2 Virus
|
||
| Completed |
NCT04327180 -
PREdiction of DIagnosed Covid-19 infecTion in IUC Patients
|
||
| Recruiting |
NCT04438629 -
Evaluation of Immune Response in COVID-19 Patients
|
||
| Active, not recruiting |
NCT05874713 -
Study to Evaluate Safety and Immunogenicity of Different Priming and Booster Regimens With Adjuvanted H5N8 and/or H5N6 Influenza Vaccine in Adults
|
Phase 2 | |
| Completed |
NCT03163628 -
biomArkers to differeNtiate bacTerial From vIral iNfEctions
|
N/A | |
| Completed |
NCT04924842 -
COVID-19 - SARS-CoV-2 Community Contamination in Children and Adults - Impact of Variants (Dyn3CEA - Nosocor Phase 2)
|
||
| Completed |
NCT04354155 -
COVID-19 Anticoagulation in Children - Thromboprophlaxis (COVAC-TP) Trial
|
Phase 2 | |
| Recruiting |
NCT05875961 -
Study to Evaluate Immunogenicity, Safety and Tolerability of Adjuvanted and Non-Adjuvanted H2N3 Influenza Vaccines in Adults
|
Phase 1 | |
| Recruiting |
NCT06379061 -
Access MeMed BV Assay Clinical Study Collection Protocol - Infectious Adult and Pediatric Cohorts
|
||
| Active, not recruiting |
NCT04481529 -
COVID-19 Serological Status of Hospital Staff Working or Not in the COVID-19 Sector
|
||
| Recruiting |
NCT05090319 -
Micro-hematology Analyzer for Viral/Bacterial Description
|
||
| Not yet recruiting |
NCT04887233 -
Efficacy and Safety of Longan Extract Spray (P80 Spray) in Volunteers With Coronavirus Disease 2019 (COVID-19)
|
N/A |